login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
RECURSION PHARMACEUTICALS-A (RXRX) Stock News
NASDAQ:RXRX -
US75629V1044
-
Common Stock
4.495
USD
-0.13 (-2.92%)
Last: 9/4/2025, 12:16:04 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
RXRX Latest News, Press Relases and Analysis
All
Press Releases
a day ago - By: The Motley Fool
- Mentions:
NVDA
NBIS
APLD
ARM
...
When You Buy Nvidia Stock, You Get a Bonus: An Artificial Intelligence (AI) ETF of Sorts
2 days ago - By: The Motley Fool
- Mentions:
PLTR
JPM
NVDA
3 AI Stocks Disrupting Trillion-Dollar Industries
7 days ago - By: Yahoo Finance
Recursion Pharmaceuticals, Inc. (RXRX) Expands Rare Disease Pipeline with REV102 Acquisition
a month ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
a month ago - By: Benzinga
Recursion Pharmaceuticals Earnings Preview
a month ago - By: Recursion Pharmaceuticals
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
8 days ago - By: Recursion Pharmaceuticals
Recursion to Participate in Upcoming Investor Conferences
10 days ago - By: Yahoo Finance
- Mentions:
NVDA
1 Reason to Buy This Beaten-Down Artificial Intelligence (AI) Stock, and 2 Reasons to Sell
13 days ago - By: Yahoo Finance
- Mentions:
MS
Why Recursion Pharmaceuticals Stock Caught a Cold This Week
14 days ago - By: Yahoo Finance
Recursion Pharmaceuticals (RXRX) Drops on 3rd Day as Company Execs Dispose of Shares
18 days ago - By: Yahoo Finance
- Mentions:
RLYB
Recursion Pharmaceuticals (RXRX) Expands AI Drug Discovery Pipeline with New Clinical Candid
18 days ago - By: Yahoo Finance
- Mentions:
NVDA
AMZN
MSFT
BAC
...
Nvidia quietly buys more stock in AI infrastructure favorite
a month ago - By: Zacks Investment Research
- Mentions:
CRMD
ARVN
IMCR
RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
a month ago - By: Yahoo Finance
Why Recursion Pharmaceuticals Stock Tanked on Tuesday
a month ago - By: Zacks Investment Research
- Mentions:
MRSN
Recursion Pharmaceuticals (RXRX) Reports Q2 Loss, Beats Revenue Estimates
a month ago - By: Recursion Pharmaceuticals
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Recursion Pharmaceuticals
Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
a month ago - By: Zacks Investment Research
- Mentions:
ZTS
ACAD
Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
a month ago - By: Yahoo Finance
- Mentions:
VKTX
2 Beaten-Down Stocks With Incredible Upside Potential
a month ago - By: Recursion Pharmaceuticals
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
a month ago - By: Yahoo Finance
- Mentions:
SHOP
The Median Retirement Savings for American Households Is $87,000. Here Are 3 Incredible Stocks to Buy Now and Hold for Decades.
a month ago - By: Yahoo Finance
- Mentions:
NVDA
Recursion Pharmaceuticals (RXRX) Jumps 9.6% Ahead of Q2 Earnings
Please enable JavaScript to continue using this application.